BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29265766)

  • 1. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
    Jhang JF; Wu SY; Lin TY; Kuo HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Jhang JF; Lin TY; Kuo HC
    Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intravesical injections of platelet-rich plasma improve symptoms and alter urinary functional proteins in patients with refractory interstitial cystitis.
    Jiang YH; Kuo YC; Jhang JF; Lee CL; Hsu YH; Ho HC; Kuo HC
    Sci Rep; 2020 Sep; 10(1):15218. PubMed ID: 32939046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
    Lee CL; Kuo HC
    Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Urothelial Cell Proliferation, Cytoskeleton and Barrier Function Protein Expression in the Patients With Interstitial Cystitis/Bladder Pain Syndrome After Intravesical Platelet-Rich Plasma Injection.
    Jhang JF; Jiang YH; Hsu YH; Ho HC; Birder LA; Lin TY; Kuo HC
    Int Neurourol J; 2022 Feb; 26(Suppl 1):S57-67. PubMed ID: 35073671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Efficacy of Intravesical Platelet-Rich Plasma Injections for Interstitial Cystitis/Bladder Pain Syndrome-A Comparative Study of Different Injection Number, Additives and Concentrations.
    Jiang YH; Jhang JF; Lin TY; Ho HC; Hsu YH; Kuo HC
    Front Pharmacol; 2022; 13():853776. PubMed ID: 35392571
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
    Jiang YH; Jhang JF; Lee CL; Kuo HC
    Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
    Lee CL; Kuo HC
    Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
    Peng CH; Jhang JF; Shie JH; Kuo HC
    Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical instillation of platelet-rich plasma for treatment of interstitial cystitis/bladder pain syndrome: A pilot study.
    El Hefnawy AS; Hasan MAA; El Sawy E; Abdel-Razik M; El-Tabey N
    Curr Urol; 2024 Mar; 18(1):49-54. PubMed ID: 38505153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical injections of autologous platelet-rich plasma for the treatment of refractory interstitial cystitis.
    Kuo HC
    Low Urin Tract Symptoms; 2023 Nov; 15(6):210-215. PubMed ID: 37702275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
    Shie JH; Liu HT; Wang YS; Kuo HC
    BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved symptoms and signs of refractory interstitial cystitis in women after intravesical Nanofat plus platelet-rich plasma grafting: A pilot study.
    Hung MJ; Tsai CP; Ying TH; Chen GD; Su HL; Tseng CJ
    J Chin Med Assoc; 2022 Jun; 85(6):730-735. PubMed ID: 35507021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the Ultrastructure of the Bladder Urothelium in Patients with Interstitial Cystitis after Intravesical Injections of Platelet-Rich Plasma.
    Lee YK; Jiang YH; Jhang JF; Ho HC; Kuo HC
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.